The below posters presented at AIBC 2022 can be viewed onsite in 2 shifts as well as online.

Shift 1: P01-P37

Posters should be mounted between 17:00-17:30 on Thursday, October 13 and removed by 13:00 on Friday, October 14.

Breast imaging
P01

DEVELOPMENT OF A CELL-SENSITIVE ELASTOGRAPHY MODEL TO DETECT ULTRA-SMALL BREAST CANCERS
Ali Farajpour OuderjiIran

P02

PET SCANS FOR LOCALLY ADVANCED BREAST CANCER AND DIAGNOSTIC MRI TO DETERMINE THE EXTENT OF OPERATION AND RADIOTHERAPY (TROG 12.02 PET LABRADOR)
Kirsten Gadsby, Australia

P03 THE APPEARANCE OF FAT NECROSIS ON CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY
Natalia GaribottoAustralia
P04 INJECTION MAMMOPLASTY: NORMAL IMAGING APPEARANCES AND IMPLICATIONS FOR MAMMOGRAPHIC SCREENING
Winfred Xi Tai GohSingapore
P05 RELATIONSHIP BETWEEN PATIENT AGE, MAMMOGRAPHIC BREAST DENSITY AND BACKGROUND PARENCHYMAL ENHANCEMENT ON CONTRAST-ENHANCED MAMMOGRAPHY
Yen HuynhAustralia
P06 CASE DIFFICULTY AS EVALUATED BY BREAST PHYSICIANS AND RADIOLOGISTS: DATA FROM THE BREAST MAMMOGRAM TEST SETS
Sarah LewisAustralia
P07 BENEFITS OF BREAST TOMOSYNTHESIS IN BREASTSCREEN ASSESSMENT CLINICS
Daniel LiuAustralia
P08 BREAST BIOPSY PRACTICE AND BREAST BIOPSY MARKER UTILISATION: AUSTRALIAN AND NEW ZEALAND PERSPECTIVE
Rose RadicAustralia
P09 BREAST BIOPSY MARKER COST AND AVAILABILITY INFLUENCES UTILISATION IN RADIOLOGY PRACTICE
Rose RadicAustralia
P10 CLINICALLY AND RADIOLOGICALLY OCCULT PAGET’S DISEASE OF THE BREAST: A 14-YEAR RETROSPECTIVE CASE SERIES AT A SINGLE TERTIARY INSTITUTION
Ananda Kallyani S.M. PonniahAustralia
DCIS
P11 LOCAL RECURRENCE IN DCIS TREATED PREDOMINANTLY WITHOUT RADIATION
Christina Kozul, Australia
P12 BREAST SURGEONS’ VIEWS ON ENDOCRINE THERAPY FOR TREATMENT OF DUCTAL CARCINOMA IN SITU
Ben LancashireAustralia
P13 ENDOCRINE THERAPY FOR TREATMENT OF DUCTAL CARCINOMA IN SITU – A CASE FOR RESEARCH IN THE AUSTRALIAN AND NEW ZEALAND SETTING
Ben LancashireAustralia
P14 NOTORIOUS DCIS WITH LOBULAR CANCERIZATION, MULTIPLE RECURRENCES AND CONTRALATERAL AXILLARY METASTASES(CAM) – A CASE REPORT
Swathi PrakashIndia
HER2 positive breast cancer
P15

PIPPA: A PROSPECTIVE OBSERVATIONAL STUDY OF MOBILE APP-BASED PATIENT-REPORTED OUTCOMES IN PATIENTS TREATED WITH PALBOCICLIB FOR ADVANCED BREAST CANCER IN AUSTRALIA
Richard De Boer, Australia

Locoregional therapy
P16 OUTCOMES OF AXILLARY CLEARANCE FOR POSITIVE MACROSCOPIC SENTINEL NODE BIOPSY IN BREAST CANCER, A REGIONAL CENTRE EXPERIENCE
Maxwell Jambor, Australia

Medical oncology

P17

SYNCHRONOUS OPERABLE PANCREATIC AND BREAST CANCER WITHOUT GENETIC MUTATION: A LITERATURE REVIEW AND DISCUSSION
Adam Ofri, Australia

Molecular assays
P18 OPTIMA, A PROSPECTIVE INTERNATIONAL RANDOMIZED TRIAL TO VALIDATE THE CLINICAL UTILITY AND COST-EFFECTIVENESS OF GENE EXPRESSION TEST-DIRECTED CHEMOTHERAPY IN HIGH CLINICAL RISK EARLY BREAST CANCER
Janet Dunn, Australia
Neoadjuvant therapy
P19 NEOADJUVANT CHEMOTHERAPY UTILISATION AND OUTCOMES IN BREAST CANCER PATIENTS AT A TERTIARY HOSPITAL IN NORTH QUEENSLAND
Tony Mallett, Australia
Pathology
P20 PARANEOPLASTIC CHOREA SECONDARY TO INVASIVE CARCINOMA OF THE BREAST: A CASE REPORT
Ali HooshyariNew Zealand
P21 WARFARIN INDUCED BREAST NECROSIS: CASE REPORT
Vaishnaivy MahendravarmanAustralia
P22 COMPARISON OF BREAST CANCER HER2 STATUS TESTING WITH IMMUNOHISTOCHEMISTRY AND IN-SITU HYBRIDISATION
Aswin Shanmugalingam, Australia
Prevention
P23 DEVELOPING ALTERNATIVE PREVENTION STRATEGIES: CAN COLLEGE STUDENTS HAVE AN  IMPACT ON BREAST CANCER SCREENING?
Adam Johnson, United States
Radiation oncology       
P24 A RETROSPECTIVE AUDIT OF DOSE AND LOCAL CONTROL IN POST-MASTECTOMY BREAST CANCER PATIENTS. IS STANDARD BOLUS REQUIRED WITH CONTEMPORARY IMRT/VMAT TREATMENT PLANNING?
Susan CarrollAustralia
P25 A REVIEW OF WOMEN WITH A SOLITARY EXTRACRANIAL METASTASIS FROM BREAST CANCER
Patrick DyerAustralia
P26 ACUTE TOXICITY IN ADJUVANT BREAST RADIOTHERAPY USING KNOWLEDGE-BASED VOLUMETRIC MODULATED ARC THERAPY PLANNING
Alexandra KnightAustralia
P27 INTERIM ANALYSIS OF THE PREDICT REGISTRY AUSTRALIA: CHANGES IN TREATMENT RECOMMENDATION FOR A BIOLOGIC SIGNATURE PREDICTIVE OF RADIATION THERAPY (RT) BENEFIT IN PATIENTS WITH DCIS
Yvonne ZissiadisAustralia
P28 INTRAOPERATIVE RADIOTHERAPY FOR EARLY BREAST CANCER: EARLY EXPERIENCE AND QUALITY OF LIFE OUTCOMES FROM A WESTERN AUSTRALIAN REGISTRY
Yvonne Zissiadis, Australia
Reconstruction 
P29 AUTOLOGOUS VERSUS IMPLANT-BASED BREAST RECONSTRUCTION: IMPACT OF SCAR QUALITY (SCAR-Q) IN BREAST AND ABDOMINAL SCARRING AND QUALITY OF LIFE (BREAST-Q) FOLLOWING BREAST RECONSTRUCTION
Nirmal Dayaratna, Australia
P30 PROSPECTIVE EVALUATION OF ROBOTIC-ASSISTED DEEP INFERIOR ARTERY PERFORATOR (DIEP) FLAP HARVEST IN BREAST RECONSTRUCTION
Nirmal DayaratnaAustralia
P31 TREATMENT OF COMPLEX BREAST WOUNDS WITH PLATELET RICH FIBRIN
Gagandip SangheraAustralia
P32 BREAST IMPLANT ASSOCIATED – ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSIS AND MANAGEMENT – CASE SERIES
Gagandip SangheraAustralia
P33 CARBON DIOXIDE VS. SALINE TISSUE EXPANDERS FOR BREAST RECONSTRUCTION – LITERATURE REVIEW AND CURRENT PRACTICE
Gagandip SangheraAustralia
P34 PATTERNS OF BREAST RECONSTRUCTION AND THE INFLUENCE OF A SURGICAL MULTIDISCIPLINARY CLINIC
Yuan TianAustralia
P35 3D BREAST SCAFFOLD RECONSTRUCTION: A PRECLINICAL ANIMAL MODEL
Clement WongAustralia
Screening
P36 BENEFITS VERSUS HARMS OF BREAST CANCER SCREENING REVISITED: A LARGE, RETROSPECTIVE COHORT STUDY QUANTIFYING ADDITIONAL TREATMENT ASSOCIATED WITH LATER DIAGNOSIS IN AUSTRALIA AND NEW ZEALAND
Kathy Dempsey, Australia
Triple negative breast cancer
P37 INVESTIGATING THE ROLE OF BANF1 IN TNBC
Maddison Rose, Australia

Shift 2: P38-P76

Posters should be mounted between 14:00-14:30 on Friday, October 14 and removed by 14:00 on Saturday, October 15.

Surgery
P38 REGIONAL BLOCK VS WOUND INFILTRATION OF LOCAL ANAESTHETIC IN ONCOLOGICAL BREAST SURGERY – A SYSTEMATIC REVIEW AND META-ANALYSIS
Tess AsgillAustralia
P39 OUTCOMES FOLLOWING RE-EXCISION OF MARGINS FOR LOBULAR BREAST CANCERS AFTER BREAST CONSERVING SURGERY- REFLECTIONS FROM THE BREASTSURGANZ QUALITY AUDIT
Philip Britten-JonesAustralia
P40 DIFFERENCES IN BREAST CANCER SURGERY IN INDIGENOUS AND NON-INDIGENOUS WOMEN IN AUSTRALIA
Nirmal DayaratnaAustralia
P41 PERCEPTION OF UPPER CHEST CHEMOTHERAPY PORT (PORT-A-CATH) SCARRING IN BREAST RECONSTRUCTION AND MASTECTOMY PATIENTS
Nirmal DayaratnaAustralia
P42 ATNEC: A RANDOMIZED TRIAL INVESTIGATING WHETHER AXILLARY TREATMENT CAN BE AVOIDED IN T1-3N1M0 BREAST CANCER PATIENTS WITH NO RESIDUAL CANCER IN THE AXILLARY NODES AFTER NEOADJUVANT CHEMOTHERAPY
Janet DunnUnited Kingdom
P43 WHAT’S THE ATTRACTION – MAGTRACE AS AN ALTERNATIVE TO LYMPHOSPHINGRAPHY IN SENTINAL NODE BIOPSY IN BREAST CANCER
Megan EmonsonAustralia
P44 LOCAL BREAST CANCER RECURRENCE FOLLOWING AUTOLOGOUS RECONSTRUCTION: CLINICAL AND RADIOLOGICAL CHALLENGES RELATING TO SURVEILLANCE
Cheng FengAustralia
P45 SYSTEMATIC REVIEW OF LONG THORACIC NERVE INJURY IN BREAST CANCER AXILLARY SURGERY
Natalia GaribottoAustralia
P46 DE-ESCALATING AXILLARY SURGERY IN BREAST CANCER: TARGETED AXILLARY DISSECTION. OUR EXPERIENCE AT THE ROYAL PERTH AND FIONA STANLEY HOSPITALS, WESTERN AUSTRALIA
Ji Gu, Australia
P47 CHYLE LEAK POST MASTECTOMY AND AXILLARY CLEARANCE: A RARE BUT CHALLENGING COMPLICATION
Ji GuAustralia
P48 PATIENT REPORTED OUTCOME MEASURES AFTER BREAST AUGMENTATION – USING THE BREAST-Q IS
Randi JayasingheAustralia
P49 INTRAOPERATIVE SENTINEL NODE ANALYSIS USING TOUCH IMPRINT CYTOLOGY – A WESTERN AUSTRALIAN EXPERIENCE OF DIAGNOSTIC ACCURACY IN  779 PATIENTS WITH BREAST CANCER
Anitha KarunairajahAustralia
P50 BORDER REOPENING AND COVID-19 PREPARATION: IMPACT ON BREAST CANCER HEALTHCARE PROVISION FROM A WEST AUSTRALIAN PERSPECTIVE
Thomas EnglandAustralia
P51 LEARNING CURVE AND SURGICAL OUTCOMES FOLLOWING INTRODUCTION OF RADIO-GUIDED OCCULT LESION LOCALISATION USING IODINE-125 SEEDS (ROLLIS) AT A TERTIARY BREAST UNIT
David LimAustralia
P52 COMPLICATIONS OF INJECTABLE BREAST AUGMENTATION 21 YEARS LATER
Oscar BrettAustralia
P53 OUTCOMES AFTER RADIOACTIVE 125-IODINE SEED LOCALISATION FOR IMPALPABLE IN SITU AND INVASIVE BREAST CANCER:  THE EARLY EXPERIENCE
Tony MallettAustralia
P54 A DISSECTION STUDY OF THE GROSS ANATOMY OF THE ATTACHMENTS OF THE FEMALE BREAST TO THE CHEST WALL
Deirdre McGheeAustralia
P55 ALTERNATIVE LOCALISATION METHOD FOR NON-PALPABLE BREAST CANCER: AUDIT OF RE-EXCISION RATES MAGSEED® LOCALIZATION OF NON-PALPABLE BREAST CANCERS IN AN AUSTRALIAN REGIONAL NON-TERTIARY HOSPITAL
Su Su NaingAustralia
P56 OCCULT BREAST CANCER: WHERE ARE WE AT?
Adam OfriAustralia
P57 DIAGNOSIS AND MANAGEMENT OF PHYLLODES TUMOURS FOR THE SURGEON: AN ALGORITHM
Adam OfriAustralia
P58 THE LIMBERG FLAP IN MASTECTOMY T-JUNCTION NECROSIS: AN UNDERUTILISED TECHNIQUE
Adam OfriAustralia
P59 OLDER BREAST CANCER: A DEDICATED SENTINEL LYMPH NODE METASTASIS NOMOGRAM
Adam Ofri, Australia
P60 BREAST SURGERY IN A TEACHING PUBLIC HOSPITAL: DOES TRAINING INCREASE COMPLICATION RATES
Adam OfriAustralia
P61 OLDER BREAST CANCER: NOT ALL T1 HR+ BREAST CANCERS ARE EQUAL
Adam OfriAustralia
P62 OLDER BREAST CANCER IN AUSTRALIA: TUMOUR CHARACTERISTICS OF SCREENED VERSUS SYMPTOMATIC BREAST CANCERS
Adam OfriAustralia
P63 BREAST SURGERY IN A TEACHING PUBLIC HOSPITAL: DOES ONCOPLASTIC TRAINING SIGNIFICANTLY IMPACT SURGICAL DURATION
Adam OfriAustralia
P64 SKIN SPARING MASTECTOMY(SSM) WITH TOTAL AUTOLOGOUS FAT GRAFTING WITH PLATELET-RICH-PLASMA(PrP) VERSUS BREAST CONSERVATION THERAPY(BCS) IN EARLY BREAST CANCER(EBC) PATIENTS: RANDOMISED CONTROLLED TRIAL(RCT) WITH FOLLOW-UP OF 34 MONTHS
Swathi PrakashIndia
P65 SENTINEL LYMPH NODE BIOPSY UNDER LOCAL ANAESTHESIA EFFECTIVE AND FEASIBLE – A 5-YEAR EXPERIENCE IN A TERTIARY CARE CENTER IN INDIA
Vandhana RajgopalIndia
P66 THE EVOLUTION OF MAGSEED™ LOCALIZATION IN THE MANAGEMENT OF IMPALPABLE BREAST CANCERS
Syed Ali Abbas RizviAustralia
P67 SENTINEL NODE RE-MAPPING IN PATIENTS WITH A SECOND PRIMARY BREAST CANCER AND PREVIOUS AXILLARY LYMPH NODE DISSECTION (ALND)
Nikolaos S. SalemisGreece
P68 MICROPOROUS POLYSACCHARIDE HEMOSPHERES (MPH) AND SEROMA FORMATION AFTER MASTECTOMY AND SENTINEL NODE BIOPSY – A PROSPECTIVE RANDOMISED CLINICAL TRIAL
Gagandip SangheraAustralia
P69 HISTORY AND EVOLUTION OF SENTINEL LYMPH NODE MAPPING
Gagandip SangheraAustralia
P70 REVIEW OF MANAGEMENT AND OUTCOMES OF BORDERLINE AND MALIGNANT PHYLLODES TUMOURS OF THE BREAST AT A UK TERTIARY CENTRE
Gausihi SivarajahAustralia
P71 BREAST FIBROMATOSIS: 2000 TO THE PRESENT
Mike WuAustralia
Survivorship      
P72 HOW THINK PINK FOUNDATION OVERCAME COVID-19 LOCKDOWNS AND FLOURISHED DURING THE PANDEMIC
Andrea Cannon, Australia
P73 MALE BREAST CANCER: A SINGAPORE PERSPECTIVE
Joshua Sheng Hao LimSingapore
P74 BREAST CANCER SURVIVORSHIP CLINIC: A PILOT STUDY
Ananda Kallyani S.M. PonniahAustralia
Symptom Management
P75 COVID-19: A RISK FACTOR FOR RECURRENT BREAST IMPLANT-RELATED SEROMA?
Diana Tam, Australia
P76 REACH, ACCEPTABILITY, USEFULNESS AND ENGAGEMENT WITH A HEALTH SUPPORT PROGRAM FOR BREAST CANCER SURVIVORS DELIVERED VIA TEXT MESSAGES: A MIXED-METHODS EVALUATION OF THE EMPOWER-SMS RANDOMISED CONTROLLED TRIAL
Anna C. Singleton, Australia

 

Skip to content